全文获取类型
收费全文 | 6729篇 |
免费 | 345篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 210篇 |
儿科学 | 155篇 |
妇产科学 | 219篇 |
基础医学 | 932篇 |
口腔科学 | 370篇 |
临床医学 | 511篇 |
内科学 | 1533篇 |
皮肤病学 | 115篇 |
神经病学 | 511篇 |
特种医学 | 141篇 |
外科学 | 1059篇 |
综合类 | 28篇 |
预防医学 | 526篇 |
眼科学 | 145篇 |
药学 | 341篇 |
中国医学 | 35篇 |
肿瘤学 | 280篇 |
出版年
2023年 | 51篇 |
2022年 | 112篇 |
2021年 | 205篇 |
2020年 | 120篇 |
2019年 | 200篇 |
2018年 | 207篇 |
2017年 | 125篇 |
2016年 | 173篇 |
2015年 | 240篇 |
2014年 | 312篇 |
2013年 | 346篇 |
2012年 | 534篇 |
2011年 | 599篇 |
2010年 | 350篇 |
2009年 | 269篇 |
2008年 | 454篇 |
2007年 | 474篇 |
2006年 | 451篇 |
2005年 | 389篇 |
2004年 | 349篇 |
2003年 | 290篇 |
2002年 | 266篇 |
2001年 | 81篇 |
2000年 | 71篇 |
1999年 | 61篇 |
1998年 | 45篇 |
1997年 | 30篇 |
1996年 | 22篇 |
1995年 | 17篇 |
1994年 | 18篇 |
1993年 | 14篇 |
1992年 | 20篇 |
1991年 | 29篇 |
1990年 | 20篇 |
1989年 | 15篇 |
1988年 | 17篇 |
1987年 | 13篇 |
1986年 | 13篇 |
1985年 | 8篇 |
1984年 | 12篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 9篇 |
1978年 | 6篇 |
1976年 | 5篇 |
1974年 | 4篇 |
1973年 | 6篇 |
1970年 | 4篇 |
排序方式: 共有7111条查询结果,搜索用时 15 毫秒
51.
Elaine Maria Seles Dorneles Ana Paula Paiva de Faria Rebeca Barbosa Pauletti Jordana Almeida Santana George Afonso Vítor Caldeira Marcos Bryan Heinemann Ricardo Titze-de-Almeida Andrey Pereira Lage 《Vaccine》2013
The aims of the present study were (i) to assess the in vitro genetic stability of S19 and RB51 Brucella abortus vaccines strains and (ii) to evaluate the ability of multiple-locus variable-number tandem repeat (VNTR) analysis (MLVA) as a tool to be used in the quality control of live vaccines against brucellosis. Sixty-three batches of commercial S19 (n = 53) and RB51 (n = 10) vaccines, produced between 2006 and 2009, were used in this study. S19 and RB51 vaccines were obtained from, respectively, seven and two different manufacturers. Ten in vitro serial passages were performed on reference strains and on selected batches of commercial vaccines. All batches, reference strains and strains of serial passages were typed by the MLVA16. The results demonstrated that B. abortus S19 and RB51 vaccine strains are genetically stable and very homogeneous in their respective groups. Anyway, batches of S19 from one manufacturer and batches of RB51 from another presented genotypes distincts from the reference vaccine strains. In both cases, differences were found on locus Bruce07, which had addition of one repeat unit in the case of S19 batches and the deletion of one repeat unit in the case of RB51 batches. In summary, MLVA16 proved to be a molecular tool capable of discriminating small genomic variations and should be included in in vitro official tests. 相似文献
52.
Marcos André C. Bezerra Magnun N.N. Santos Aderson S. Araújo Yara M. Gomes Frederico G.C. Abath 《Hemoglobin》2013,37(1):83-88
Various factors have been described as phenotypic modulators of sickle cell disease, such as levels of fetal hemoglobin (Hb F), presence of α-thalassemia (thal), and haplotypes of the β-globin genes. In order to characterize and determine the frequency of the βS and βC mutations and the prevalence of ?α3.7-thal, 74 patients with sickle cell disease detected during neonatal screening in the State of Pernambuco, Brazil, were studied. The haplotypes of the β gene and ?α3.7-thal were determined using polymerase chain reaction (PCR), and specific restriction endonucleases were used to establish the polymorphic sites of the haplotypes. The results showed the high frequency of the Central African Republic (CAR) or Bantu haplotype in the State of Pernambuco, Brazil. The low frequency of the Benin haplotype recorded in this study, in comparison with other states in northeast Brazil, suggests the diversity of origins of Afro-Brazilians in this region. 相似文献
53.
54.
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia 总被引:10,自引:6,他引:10 下载免费PDF全文
Kantarjian HM O'Brien S Cortes JE Giralt SA Rios MB Shan J Giles FJ Thomas DA Faderl S De Lima M Garcia-Manero G Champlin R Arlinghaus R Talpaz M 《Blood》2002,100(5):1590-1595
Twenty-eight adults with chronic myelogenous leukemia (CML) that had relapsed after allogeneic stem cell transplantation (SCT) received imatinib mesylate (400-1000 mg/d). Disease was in chronic phase in 5 patients, accelerated in 15, and blastic in 8 (7 medullary, 1 extramedullary); median time from transplantation to relapse was 9 months (range, 1-137 months). Thirteen patients had undergone salvage donor lymphocyte infusion (DLI) (median time from DLI to imatinib mesylate therapy, 4 months [range, 2-39 months]). The overall response rate was 79% (22 of 28 patients); the complete hematologic response (CHR) rate was 74% (17 of 23 patients), and the cytogenetic response rate was 58% (15 of 26 patients; complete response in 9 [35%] patients). CHR rates were 100% for chronic phase, 83% for accelerated phase, and 43% for blastic phase. The patient with extramedullary blastic disease achieved complete response. Cytogenetic response rates were 63% (12 of 19 patients) for chronic or accelerated phases (complete cytogenetic response in 8) and 43% for blastic phase (3 of 7 patients). At median follow-up of 15 months, 19 patients were alive, 9 with no evidence of disease. The 1-year estimated survival rate was 74%. Five patients had recurrence of grade 3 (3 patients) or grades 1 to 2 (2 patients) graft-versus-host disease (GVHD). Severe granulocytopenia developed in 43% of patients and thrombocytopenia in 27%; both conditions reversed with dose adjustments of imatinib mesylate. We conclude that imatinib mesylate effectively controlled CML that recurred after allogeneic SCT, but it was associated with side effects including myelosuppression and recurrence of severe GVHD. 相似文献
55.
Peter U. Fischer Kurt C. Curtis Scott M. Folk Patricia P. Wilkins Luis A. Marcos Gary J. Weil 《The American journal of tropical medicine and hygiene》2013,88(6):1035-1040
We studied the value of an IgG Western blot (WB) with Paragonimus kellicotti (Pk) antigen for diagnosis of North American paragonimiasis. The test was evaluated with sera from patients with Pk and Paragonimus westermani infections, with control sera from patients with other helminth infections, and sera from healthy Americans. All 11 proven Pk infection sera and two samples from suspected cases that were negative by P. westermani WB at the Centers for Disease Control and Prevention (CDC) contained antibodies to antigens at 34 kDa and at 21/23 kDa. Seven of 7 P. westermani sera contained antibodies to the 34 kDa antigen, but only 2 recognized the 21/23 kDa doublet. No control samples were reactive with these antigens. Antibody reactivity declined after praziquantel treatment. Thus, the P. kellicotti WB appears to be superior to P. westermani WB for diagnosing Pk infections, and it may be useful for assessing responses to treatment. 相似文献
56.
57.
Evelien Meulenijzer Krishna Vyncke Idoia Labayen Aline Meirhaeghe Laurent Béghin Christina Breidenassel Vanesa España-Romero Υannis Manios Marika Ferrari Luis A. Moreno Frédéric Gottrand Stefaan De Henauw Marcela González-Gross Anthony Kafatos Kurt Widhalm Dénes Molnár Michael Sjöstrom Ascensión Marcos Odysseas Androutsos Julia Wärnberg Chantal C. Gilbert Inge Huybrechts 《European journal of pediatrics》2015,174(2):271-278
58.
59.
Debora M. Miranda Bernardo L. Wajchenberg† Maria R. Calsolari‡ Marcos J. Aguiar José M. C. L. Silva§ Marcia G. Ribeiro¶ Cristina Fonseca¶ Daniela Amaral¶ Wolfanga L. Boson Bruna A. Resende Luiz De Marco 《Clinical endocrinology》2009,71(4):512-517
Context Congenital generalized lipodystrophy, or Berardinelli–Seip syndrome, is a rare autosomal recessive disease caused by mutations in either the BSCL2 or AGPAT2 genes. This syndrome is characterized by an almost complete loss of adipose tissue usually diagnosed at birth or early infancy resulting in apparent muscle hypertrophy. Common clinical features are acanthosis nigricans, hepatomegaly with or without splenomegaly and high stature. Acromegaloid features, cardiomyopathy and mental retardation can also be present.
Design We investigated 11 kindreds from different geographical areas of Brazil (northeast and southeast). All coding regions as well as flanking intronic regions of both genes were examined. Polymerase chain reaction (PCR) amplifications were performed using primers described previously and PCR products were sequenced directly.
Results Four AGPAT2 and two BSCL2 families harboured the same set of mutations. BSCL2 gene mutations were found in the homozygous form in four kindreds (c.412C>T c.464T>C, c.518–519insA, IVS5-2A>G), and in two kindreds compound mutations were found (c.1363C>T, c.424A>G). In the other four families, one mutation of the AGPAT2 gene was found (IVS3-1G>C and c.299G>A).
Conclusions We have demonstrated four novel mutations of the BSCL2 and AGPAT2 genes responsible for Berardinelli–Seip syndrome and Brunzell syndrome (AGPAT2-related syndrome). 相似文献
Design We investigated 11 kindreds from different geographical areas of Brazil (northeast and southeast). All coding regions as well as flanking intronic regions of both genes were examined. Polymerase chain reaction (PCR) amplifications were performed using primers described previously and PCR products were sequenced directly.
Results Four AGPAT2 and two BSCL2 families harboured the same set of mutations. BSCL2 gene mutations were found in the homozygous form in four kindreds (c.412C>T c.464T>C, c.518–519insA, IVS5-2A>G), and in two kindreds compound mutations were found (c.1363C>T, c.424A>G). In the other four families, one mutation of the AGPAT2 gene was found (IVS3-1G>C and c.299G>A).
Conclusions We have demonstrated four novel mutations of the BSCL2 and AGPAT2 genes responsible for Berardinelli–Seip syndrome and Brunzell syndrome (AGPAT2-related syndrome). 相似文献
60.
Stump PR Baccarelli R Marciano LH Lauris JR Teixeira MJ Ura S Virmond MC 《International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association》2004,72(2):134-138
The introduction of multidrug therapy by the World Health Organization has dramatically reduced the world prevalence of leprosy but the disease is still a public health problem in many countries, with a world prevalence of almost 600,000 cases in 2001. Damage to peripheral nerves is a key component of leprosy and the sensory and motor loss that follows is the basis for many of the classical features of this disease, such as skin wounds, cracks, plantar ulcers, clawed hands, drop foot, and incomplete closure of the eyelids. One of the most remarkable aspects of leprosy to lay persons and health care workers alike is that patients are reputed to feel no pain. However, neuropathic pain is arising as a major problem among leprosy patients. It can be nociceptive due to tissue inflammation, which mostly occurs during episodes of immune activation or neuropathic due to damage or dysfunction of the nervous system. This study, conducted among 358 leprosy patients, reveals a considerable prevalence of neuropathic pain and presents evidence that this common problem should be a high priority of those in charge of leprosy control programs. 相似文献